HSL Mobile App 
52 week Low
2,519.95
2,519.95
52 week High
3,590.70
3,590.70
3246.40
Day low
3,209.20
3,209.20
Day high
3,272.90
3,272.90
3246.40
Prev Close
3,254.60
3,254.60
Open
3,269.60
3,269.60
6M return
-4.31%
-4.31%
1Y return
25.25%
25.25%
MCap(Rs. in Cr.)
1,10,145.51
1,10,145.51
Total Volume
4,73,579
4,73,579
Face Value : 5
Listed Since
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
59.13940
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
55.02
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
14.64
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
66.51%
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
0.86
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
3282.27
3282.27
Resistance 2
3309.93
3309.93
Support 1
3228.97
3228.97
Support 2
3203.33
3203.33
Moving Average
20 Days
3222.84
3222.84
50 Days
3133.94
3133.94
100 Days
3225.64
3225.64
200 Days
3244.15
3244.15
Growth in 3 years
Sales
26.09%
Sales Industry Avg
31.22%
PAT
113.13%
PAT Industry Avg
27.90%
26.09%
Sales Industry Avg
31.22%
PAT
113.13%
PAT Industry Avg
27.90%
| Dec 2024 ( in Cr.) | Sep 2024 ( in Cr.) | Jun 2024 ( in Cr.) | Mar 2024 ( in Cr.) | FY 2024 ( in Cr.) | |
|---|---|---|---|---|---|
| Sales | 2,809 | 2,889 | 2,859 | 2,745 | 10,727.84 |
| Gross Profit | 890 | 859 | 853 | 834 | 3,160.38 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 656 | 609 | 583 | 591 | 2,352.11 |
| Tax | 153 | 156 | 126 | 142 | 695.73 |
| Profit After Tax | 503 | 453 | 457 | 449 | 1,656.38 |
Growth in 3 years
Total Asset Growth
8.96%
Total Liabilities growth
8.96%
Reserves Change
13.95%
8.96%
Total Liabilities growth
8.96%
Reserves Change
13.95%
| Mar 2024 ( in Cr.) | Mar 2023 ( in Cr.) | Mar 2022 ( in Cr.) | Mar 2021 ( in Cr.) | Mar 2019 ( in Cr.) | |
|---|---|---|---|---|---|
| Share Capital | 169.23 | 169.23 | 84.62 | 84.62 | 84.62 |
| Reserves And Surplus | 6,686.92 | 6,028.84 | 5,868.33 | 5,752.55 | 4,639.73 |
| Investments | 172.84 | 198.79 | 226.31 | 181.14 | 353.44 |
| Total Debt | 4,476.83 | 5,783.95 | 4,447.85 | 5,256.72 | 6,348.93 |
| Total Liabilities | 11,332.98 | 11,982.02 | 10,400.80 | 11,093.89 | 11,073.28 |
| Total Assets | 11,332.98 | 11,982.02 | 10,400.80 | 11,093.89 | 11,073.28 |
280%
Dividend
Date:03 Feb 2023
Dividend Percentage:280
Dividend Type:Interim
160%
Dividend
Date:23 Jun 2023
Dividend Percentage:160
Dividend Type:Final
2023
440%
Dividend
Date:12 Feb 2024
Dividend Percentage:440
Dividend Type:Interim
120%
Dividend
Date:21 Jun 2024
Dividend Percentage:120
Dividend Type:Final
2024 2025
520%
Dividend
Date:31 Jan 2025
Dividend Percentage:520
Dividend Type:Interim
2026
Relative to Sensex rtn in 3 year
245.67%
Relative to Nifty rtn in 3 year
232.29%
Relative to top 3 MF rtn in 3 year
245.67%
Relative to Nifty rtn in 3 year
232.29%
Relative to top 3 MF rtn in 3 year
| 1 Year (%) | 2 Year (%) | 3 Year (%) | |
|---|---|---|---|
| Torrent Pharma. | 25 | 101 | 129 |
| Bse Sensex | 8 | 33 | 37 |
| Nifty 50 | 8 | 37 | 39 |
| Nifty Next 50 | 5 | 71 | 52 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Torrent Pharma.
3246.40 chg : -8.20 (-0.25%)
3246.40 chg : -8.20 (-0.25%)
Sun Pharma.Inds.
1747.40 chg : 2.50 (0.14%)
1747.40 chg : 2.50 (0.14%)
Divi`s Lab.
5911.50 chg : 20.00 (0.34%)
5911.50 chg : 20.00 (0.34%)
Cipla
1528.20 chg : 17.10 (1.13%)
1528.20 chg : 17.10 (1.13%)
Mankind Pharma
2579.50 chg : -8.90 (-0.34%)
2579.50 chg : -8.90 (-0.34%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
My investment would be worth 1,25,251.70 with a Gain of 25.25%
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
Institutional Reports 11 Apr 2025 4:18 PM
The India Pharma & Healthcare sector is expected to see steady growth and margin improvement during Q4FY25E. We project sales/EBITDA growth of 13%/19% YoY for our coverage universe. Our assumptions a..
Institutional Reports 03 Apr 2025 12:14 PM
The US government under Trump 2.0 has announced reciprocal tariffs across countries, including ~26% tariff on imports from India. However, pharmaceutical products were exempted from the first round o..
Institutional Reports 25 Jan 2025 7:56 AM
Torrent Pharma: EBITDA (+5% YoY) growth was muted due to 3% YoY sales growth (strong 12% YoY growth in India despite the absence of Insulin CMO sales, -7% YoY in Brazil, and +4% in Germany) which was..
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
D
Dividend
Date:03 Feb 2023
Dividend Percentage:280
D
2023 Dividend
Date:23 Jun 2023
Dividend Percentage:160
D
Dividend
Date:12 Feb 2024
Dividend Percentage:440
D
2024 Dividend
Date:21 Jun 2024
Dividend Percentage:120
D
2025 Dividend
Date:31 Jan 2025
Dividend Percentage:520
Our Research Analysis
As of today
__PERCENT__%
Target Achived
__PERCENT__%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
CMP : __CMP__
Target : __TARGET__
Stop Loss : __STOPLOSS__
Reco Price : __RECOPRICE__
Reco Date :__RECODATE__
Call Type :__CALLTYPE__
__Rationale__
__RECOTYPE__ __COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View __RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
Torrent Pharmaceuticals Ltd 3,256.10 Chg: -1.20(-0.04%) Expiry Month 24 Apr 2025
Day's Low
3,214.60
3,214.60
3,256.10
Day's High
3,271.00
3,271.00
Day’s Open
3,255.20
3,255.20
Prev Close
3,257.30
3,257.30
Volume
10,24,500
10,24,500
OI
9,79,250
9,79,250
OI Change (%)
-39.61
-39.61
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| No data available | |||
News
Stay tuned to the latest developments and happenings in the company.
Torrent Pharmaceuticals announces resignation of ED (Strategic Planning)
Torrent Pharmaceuticals announced that Pranav Mehta, Executive Director (Strategic Planning) designated as Senior Management Personnel of the Company....
27 Feb 2025 18:47Torrent Pharmaceuticals consolidated net profit rises 13.54% in the December 2024 quarter
Net profit of Torrent Pharmaceuticals rose 13.54% to Rs 503.00 crore in the quarter ended December 2024 as against Rs 443.00 crore during the previous....
24 Jan 2025 17:35Board of Torrent Pharmaceuticals recommends interim dividend
Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 24 January 2025, inter alia, have recommended the ....
24 Jan 2025 17:25Torrent Pharmaceuticals to declare Quarterly Result
Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24 January 2025.Powered by Capital Market - Live ....
15 Jan 2025 10:12Torrent Pharmaceuticals consolidated net profit rises 17.36% in the September 2024 quarter
Net profit of Torrent Pharmaceuticals rose 17.36% to Rs 453.00 crore in the quarter ended September 2024 as against Rs 386.00 crore during the previou....
26 Oct 2024 07:40__heading__
Published on __date__ at __time__
__description__
